Raphael Townshend
Raphael Townshend is the Founder and Chief Executive Officer at Atomic AI, a biotechnology company using artificial intelligence to enable the next generation of RNA drug discovery. Prior to founding Atomic AI, Raphael completed his PhD at Stanford University, where he wrote his thesis on Geometric Learning of Biomolecular Structure and taught in Stanford’s machine learning and computational biology programs. He has been recognized in Forbes 30 Under 30, and his work has been featured on the cover of Science, recognized by a Best Paper award at NeurIPS, and published in other top venues such as Nature, Cell, and ICLR. During his PhD program, Raphael also held positions at DeepMind and Google on their artificial intelligence and software engineering teams and founded the inaugural workshop on machine learning and structural biology.
Atomic AI
AI x RNA: Foundation Models for Rational Drug Design
-
Atomic AI operates at the convergence of artificial intelligence and RNA drug discovery — two revolutionary fields with significant potential, yet not without challenges. In developing an RNA foundation model for rational drug design, Atomic pioneered novel approaches to generate, process, and model RNA data (structure, function, and interactions) from first principles. This talk will reveal their methodological journey, critical insights gained, and identify persistent gaps in the broader field that currently constrain AI's capacity to transform drug discovery.
Conference Pass
2,495
USD
Keynotes & Firesides
Workshops & Breakouts
1:1 Partnering App
Meals & Receptions
Session Recordings
Until Friday April 18th
Full Rate:
$3,495
